Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Artiva Biotherapeutics, Inc. (ARTV) had Debt to Equity Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-21.25M |
|
-- |
|
-- |
|
$22.81M |
|
$-22.81M |
|
$1.56M |
|
$-21.25M |
|
$-21.25M |
|
$-21.25M |
|
$-21.25M |
|
$-21.25M |
|
$-21.25M |
|
$-22.81M |
|
$-22.17M |
|
24.38M |
|
24.38M |
|
$-0.87 |
|
$-0.87 |
|
| Balance Sheet Financials | |
$149.07M |
|
$6.89M |
|
$20.32M |
|
$169.39M |
|
$10.77M |
|
-- |
|
$9.58M |
|
$20.35M |
|
$149.04M |
|
$149.04M |
|
$149.04M |
|
24.39M |
|
| Cash Flow Statement Financials | |
$-42.82M |
|
$31.09M |
|
$0.17M |
|
$40.49M |
|
$28.93M |
|
$-11.56M |
|
$3.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.84 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.00 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.26% |
|
-14.26% |
|
-12.55% |
|
-14.26% |
|
$6.11 |
|
$-1.82 |
|
$-1.76 |
|